-
Sector Analysis
NewNuclear Imaging Agents Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Nuclear Imaging Agents Market Report Overview The nuclear imaging agents market size was $998 million in 2023. Factors such as technical advancements and applied research will drive the market growth at a CAGR of more than 2% from 2023 to 2033. Nuclear imaging is a non-invasive medical technique that uses radioactive tracers (generally F-18 Fluorodeoxyglucose) to assess and diagnose bodily functions and diseases. The diseases include cancers, cardiac diseases, gastrointestinal, endocrine, and neurological diseases. Nuclear Imaging Agents Market Outlook 2023-2033...
-
Sector Analysis
NewX-Ray Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
X-Ray Systems Market Report Overview The X-ray Systems market size was $3.04 billion in 2023 and will grow at a CAGR of more than 2% during 2023-2033. The increasing prevalence of various chronic diseases, cardiac diseases, and neurological diseases has resulted in increased demand for medical imaging services. X-Ray Systems Market Outlook 2023-2033 ($ Billion) Buy the Full Report for More Insights on the X-ray systems Market Forecast Download a Free Sample Report The X-ray Systems market research report identifies...
-
Product Insights
NewLikelihood of Approval Analysis for Sphingolipidoses
Overview How likely is it that the drugs in Sphingolipidoses will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sphingolipidoses Overview Sphingolipidoses are a heterogeneous group of inherited disorders of lysosomal storage...
-
Sector Analysis
NewMagnetic Resonance Imaging (MRI) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Magnetic Resonance Imaging (MRI) Systems Market Report Overview The MRI systems market size was $5.73 billion in 2023 and will grow at a CAGR of more than 4% during 2023-2033. The increasing prevalence of the aging population and an increase in awareness regarding the importance of early diagnosis of disease which helps in early treatment will fuel the market growth in the coming years. Magnetic Resonance Imaging Systems Market Outlook 2023-2033 ($ Billion) Buy the Full Report for More Insights...
-
Sector Analysis
NewContrast Agents Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Contrast Agents Market Report Overview The contrast agents market size was $3.41 billion in 2023. Factors such as the rising prevalence of chronic diseases and the increased demand for cost-effective and quality healthcare will drive the market growth at a CAGR of more than 2% from 2023 to 2033. Contrast agents are used in radiology to get clearer visualizations of various medical conditions and pathologies. These agents are used with computed tomography (CT), magnetic resonance imaging (MRI), and ultrasounds, among...
-
Sector Analysis
NewPolymerase Chain Reaction (PCR) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
The PCR Market Report Overview The PCR market size was $700.3 million in 2023. Factors such as recent technological advances will drive the market growth at a CAGR of more than 5% from 2023 to 2033. Polymerase Chain Reaction (PCR) systems are used for nucleic acid amplification. They are commonly employed in investigations related to the diagnosis or prognosis of cancer or infectious diseases. The Polymerase chain reaction (PCR) is a method used to amplify short DNA or RNA sequences...
-
Product Insights
NewLikelihood of Approval Analysis for Ulcerative Colitis
Overview How likely is it that the drugs in Ulcerative Colitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ulcerative Colitis Overview Ulcerative colitis (UC) is one of the two types...
-
Sector Analysis
NewHematology Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Hematology Analyzers Market Report Overview The hematology analyzers market size was valued at $941.8 million in 2023. Factors such as the rising prevalence of diseases, including anemia, blood cancers, and disorders will primarily drive the hematology analyzers market growth. The hematology analyzers market will grow at a CAGR of more than 4% from 2023 to 2033. Hematology analyzers are used to perform tests related to blood and blood components. It is also used to identify and determine the morphology of...
-
Product Insights
NewLikelihood of Approval Analysis for Malignant Fibrous Histiocytoma
Overview How likely is it that the drugs in Malignant Fibrous Histiocytoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Malignant Fibrous Histiocytoma Overview Malignant fibrous histiocytoma, now termed undifferentiated pleomorphic...
-
Sector Analysis
NewPTA Balloon Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
PTA Balloon Catheters Market Report Overview The PTA balloon catheters market size was valued at $2.03 billion in 2023 and will grow at a CAGR of more than 4% from 2023 to 2033. The aging population, the high prevalence of the disease in developed countries, and the development of new and improved diagnostic modalities have contributed to increased treatment rates using minimally invasive techniques, such as angioplasty and stenting. These minimally invasive procedures are used to open narrowed and occluded...